HL7 v2.5.1 Vocabulary
0.1.0 - ci-build

HL7 v2.5.1 Vocabulary, published by HL7/FO. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/frankoemig/hl7.v2.terminology.v251/ and changes regularly. See the Directory of published versions

## CodeSystem: Manufacturers of Vaccines (code=MVX) (2.5.1 - 1.2.0) (Experimental)

Official URL: http://terminology.hl7.org/v2plusvocab/CodeSystem/PH_ManufacturersOfVaccinesMVX_CDC_NIP | Version: 1.2.0
Active as of 2026-01-27 | Computable Name: PH_ManufacturersOfVaccinesMVX_CDC_NIP
Other Identifiers: OID:2.16.840.1.113883.12.227
Copyright/Legal: HL7 Inc., 2026

Table of codes specifying the organization that manufactures a vaccine. The values are maintained by the US Centers of Disease Control. Note that the source of truth for these code values are maintained by the CDC, and the code system may be accessed at URL: https://phinvads.cdc.gov/vads/SearchCodeSystems_search.action?searchOptions.searchText=PH_ManufacturersOfVaccinesMVX_CDC_NIP. The value set is also maintained by the CDC, and may be accessed at URL: https://phinvads.cdc.gov/vads/SearchValueSets_search.action?searchOptions.searchText=PHVS_ManufacturersOfVaccinesMVX_CDC_NIP

This Code system is referenced in the content logical definition of the following value sets:

- PHVS_ManufacturersOfVaccinesMVX_CDC_NIP

Properties

This code system defines the following properties for its concepts

Name | Code | URI | Type | Description
versionIntroduced | versionIntroduced | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionIntroduced | string | version when was this code introduced
versionDeprecated | versionDeprecated | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionDeprecated | string | version when was this code deprecated
status | status | http://hl7.org/fhir/concept-properties#status | code | A code that indicates the status of the concept. Typical values are active, experimental, deprecated, and retired
comment | comment | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#comment | string | A string that provides additional detail pertinent to the use or understanding of the concept
usage | usage | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#usage | string | usage notes for this code
modified | modified | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#modified | dateTime | date of last modification

Concepts

This case-sensitive code system `http://terminology.hl7.org/v2plusvocab/CodeSystem/PH_ManufacturersOfVaccinesMVX_CDC_NIP` defines the following codes:

Code | Display | Definition | versionIntroduced
AB | Abbott Laboratories | Abbott Laboratories | 2.3
AD | Adams Laboratories, Inc. | Adams Laboratories, Inc. | 2.3
ALP | Alpha Therapeutic Corporation | Alpha Therapeutic Corporation | 2.3
AR | Armour | Armour | 2.3
AVB | Aventis Behring L.L.C. | Aventis Behring L.L.C. | 2.5
AVI | Aviron | Aviron | 2.3.1
BA | Baxter Healthcare Coporation] | Baxter Healthcare Coporation] | 2.3
BAH | Baxter Health Corporation | Baxter Health Corporation | 2.5
BAY | Bayer Corporation | Bayer Corporation | 2.3
BP | Berna Products | Berna Products | 2.3
BPC | Berna Products Corporation | Berna Products Corporation | 2.3.1
CEN | Centeon L.L.C. | Centeon L.L.C. | 2.3.1
CHI | Chiron Corporation | Chiron Corporation | 2.3.1
CMP | Celltech Medeva Pharmaceuticals | Celltech Medeva Pharmaceuticals | 2.5
CON | Connaught | Connaught | 2.3
EVN | Evans Medical Limited | Evans Medical Limited | 2.3
GRE | Greer Laboratories, Inc. | Greer Laboratories, Inc. | 2.3
IAG | Immuno International AG | Immuno International AG | 2.3.1
IM | Merieux | Merieux | 2.3
IUS | Immuno-U.S., Inc. | Immuno-U.S., Inc. | 2.3
JPN | The Research Foundation for Microbial Diseases of Osaka University | The Research Foundation for Microbial Diseases of Osaka University | 2.3
KGC | Korea Green Cross Corporation | Korea Green Cross Corporation | 2.3
LED | Lederle | Lederle | 2.3
MA | Massachusetts Public Health Biologic Laboratories | Massachusetts Public Health Biologic Laboratories | 2.3
MBL | Massachusetts Biologic Laboratories | Massachusetts Biologic Laboratories | 2.5
MED | MedImmune, Inc. | MedImmune, Inc. | 2.3.1
MIL | Miles | Miles | 2.3
MIP | Bioport Corporation | Bioport Corporation | 2.3
MSD | Merck & Co., Inc. | Merck & Co., Inc. | 2.3
NAB | NABI | NABI | 2.3
NAV | North American Vaccine, Inc. | North American Vaccine, Inc. | 2.3.1
NOV | Novartis Pharmaceutical Corporation | Novartis Pharmaceutical Corporation | 2.3.1
NYB | New York Blood Center | New York Blood Center | 2.3
ORT | Ortho-Clinical Diagnostics. | Ortho-Clinical Diagnostics. | 2.3.1
OTC | Organon Teknika Corporation | Organon Teknika Corporation | 2.3
OTH | Other manufacturer | Other manufacturer | 2.3
PD | Parkedale Pharmaceuticals | Parkedale Pharmaceuticals | 2.3
PMC | Aventis Pasteur Inc. | Aventis Pasteur Inc. | 2.3.1
PRX | Praxis Biologics | Praxis Biologics | 2.3
PWJ | PowerJect Pharamaceuticals | PowerJect Pharamaceuticals | 2.5
SCL | Sclavo, Inc. | Sclavo, Inc. | 2.3
SI | Swiss Serum and Vaccine Inst. | Swiss Serum and Vaccine Inst. | 2.3
SKB | GlaxoSmithKline | GlaxoSmithKline | 2.3
UNK | Unknown manufacturer | Unknown manufacturer | 2.3
USA | United States Army Medical Research and Material Command | United States Army Medical Research and Material Command | 2.3.1
WA | Wyeth-Ayerst | Wyeth-Ayerst | 2.3
WAL | Wyeth-Ayerst | Wyeth-Ayerst | 2.3.1